The rush to adrenaline: drugs in sport acting on the β‐adrenergic system
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Athletes attempt to improve performance with drugs that act on the β‐adrenergic system directly or indirectly. Of three β‐adrenoceptor (AR) subtypes, the β 2‐AR is the main target in sport; they have bronchodilator and anabolic actions and enhance anti‐inflammatory actions of corticosteroids. Although demonstrable in animal experiments and humans, there is little evidence that these properties can significantly improve performance in trained athletes. Their actions may also be compromised by receptor desensitization and by common, naturally occurring receptor mutations (polymorphisms) that can influence receptor signalling and desensitization properties in individuals. Indirectly acting agents affect release and reuptake of noradrenaline and adrenaline, thereby influencing all AR subtypes including the three β‐ARs. These agents can have potent psychostimulant effects that provide an illusion of better performance that does not usually translate into improvement in practice. Amphetamines and cocaine also have considerable potential for cardiac damage. β‐AR antagonists (β‐blockers) are used in sports that require steadiness and accuracy, such as archery and shooting, where their ability to reduce heart rate and muscle tremor may improve performance. They have a deleterious effect in endurance sports because they reduce physical performance and maximum exercise load. Recent studies have identified that many β‐AR antagonists not only block the actions of agonists but also activate other (mitogen‐activated PK) signalling pathways influencing cell growth and fate. The concept that many compounds previously regarded as ‘blockers’ may express their own spectrum of pharmacological properties has potentially far‐reaching consequences for the use of drugs both therapeutically and illicitly. British Journal of Pharmacology(2008)154, 584–597; doi:fn2
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guide to receptors and channels (GRAC), 5th edition
Alexander, S., Mathie, A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_1.x · Cited by 1,947
Unexpected evidence for active brown adipose tissue in adult humans
Nedergaard, J., Bengtsson, T., & Cannon, B. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00691.2006 · Cited by 1,824 · cited 1×
“, 1983) Increase Increase Increase Brown adipose tissue—thermogenesis (Nedergaard et al., 2007) Increase Pancreas—glucagon, insulin secretion (Mariani et al.”
BackgroundShekelle, P. G., Hardy, M. L., Morton, S. C., Maglione, M., Mojica, W. A., Suttorp, M. J., Rhodes, S. L., Jungvig, L., & Gagné, J. (2003) · JAMA · doi:10.1001/jama.289.12.1537 · Cited by 511 · cited 1×
“…to have ‘fat burning’ activity; however, a meta-analysis examining the efficacy of ephedrine (in doses ranging from 20–150 mgday 1) on weight loss suggests that this effect is small, with a shortterm loss of approximately 0.9kg month 1 more than placebo (Boozer et al., 2002; Shekelle et al., 2003).”
BackgroundHerbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial
Boozer, C., Daly, P., Homel, P., Solomon, J., Blanchard, D., Nasser, J., Strauss, R., & Meredith, T. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802023 · Cited by 203 · cited 2×
“9kg month 1 more than placebo (Boozer et al., 2002; Shekelle et al., 2003).”
BackgroundBell, D. G., Jacobs, I., & Zamecnik, J. (1998) · European Journal of Applied Physiology · doi:10.1007/s004210050355 · Cited by 96
Cited by
Doping in sport: effects, harm and misconceptions
Birzniece, V. (2015) · Internal Medicine Journal · doi:10.1111/imj.12629 · Cited by 99
Rapid induction of REDD1 gene expression in macrophages in response to stress-related catecholamines
Yanagawa, Y., Hiraide, S., Matsumoto, M., & Togashi, H. (2014) · Immunology Letters · doi:10.1016/j.imlet.2013.12.015 · Cited by 16
Zhuang, C., Liu, D., Yang, X., Wang, H., Han, L., & Li, Y. (2016) · Chemosphere · doi:10.1016/j.chemosphere.2016.01.084 · Cited by 11
Metadata
- Authors
- Davis, E., Loiacono, R., & Summers, R. J.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2008-06
- Volume
- 154
- Issue
- 3
- Pages
- 584-597
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2068222071
- Cited by
- 103
- References
- 5
- FWCI
- 16.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.